UNDER DEVELOPMENT — Do not use this website as a medical reference.

Drug Search Drug Classes Switching Guides About

Home ›Drug Classes ›CD22-directed Immunoconjugate

CD22-directed Immunoconjugate

EPCDailyMed

Drugs in this class (1)

Inotuzumab ozogamicin(Besponsa)Same Class

Medical Disclaimer: The information on RxSaurus is for educational and reference purposes only and does not constitute medical advice, clinical recommendations, or a substitute for professional medical consultation. RxSaurus does not establish a provider-patient or pharmacist-patient relationship. Always consult a qualified healthcare professional before making any medication changes. Reliance on any information provided by RxSaurus is solely at your own risk. Full Medical Disclaimer

Drug information on this site is derived from publicly available regulatory databases including DailyMed (National Library of Medicine/NIH), the openFDA API (U.S. Food and Drug Administration), the FDA Orange Book, and the RxNorm terminology system (NLM/NIH). This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. The U.S. FDA does not endorse this product. Drug information may not reflect the most recently approved labeling. Always verify current prescribing information before clinical use. Learn more about our data sources.

About Editorial Policy Medical Advisory Board Medical Disclaimer Terms of Service Privacy Policy Data Sources Contact

© 2026 RxSaurus. All rights reserved.

RxSaurus is not affiliated with any pharmaceutical manufacturer or health insurance company.